Alcami unveils new conditions and services at state-of-the-art pharma storage facility in Garner

Central North Carolina pharma storage facility now offers extensive cold and stability conditions plus full suite of material support services

DURHAM, N.C., July 23, 2024 /PRNewswire/ — Alcami Corporation (“Alcami”), a leading contract development and manufacturing organization (CDMO), has significantly expanded the cold, stability, and custom storage options at its new 65,000 ft2 state-of-the-art pharma storage facility in Garner. With a prime location near the Research Triangle Park (RTP) biotech and pharma hub, the best-in-class facility offers diverse, customizable, scalable, long-term storage conditions for temperature-sensitive vaccines, biopharma therapies, cell banks, tissues, pharmaceutical compounds, raw materials, components and medical devices.

“Alcami’s new facility is well positioned to fill previously unmet market demand,” said Laurent Boer, President, Alcami Pharma Storage and Services. “The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency.”

After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.

The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami’s high-quality, secure GMP storage network to six U.S. locations across the Northeast, Southeast, and West Coast. Alcami’s network covers a wide range of GMP temperature storage conditions, from ≤-135˚C to 70˚C, including all ICH stability conditions. Alcami’s new location further positions the company to address pharma supply chain risk mitigation with storage locations throughout the U.S.

Since opening its new Garner site in January, Alcami has created 25 new jobs onsite, including skilled operations technicians and specialists, quality/regulatory specialists, and site managers. This facility is yet another step in the company’s growth and steadfast investment and commitment to the Research Triangle Park and the state of North Carolina.

To book a site tour or speak with Alcami, click here.

About Alcami
Alcami is a contract development and manufacturing organization headquartered in NC with 45+ years of experience advancing products through the development lifecycle. Alcami provides fully integrated lab services along with drug product manufacturing, GMP pharma storage, and support services including environmental monitoring, calibration, validation and metrology. Alcami’s private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners. For more information, please visit alcami.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/alcami-unveils-new-conditions-and-services-at-state-of-the-art-pharma-storage-facility-in-garner-302203296.html

SOURCE Alcami Corporation

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago